05.09.2016 Views

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ERS International Congress 2016<br />

DETAILED PROGRAMME<br />

MONDAY 05 SEPTEMBER, 2016<br />

08:10<br />

08:20<br />

08:30<br />

Best practices for interactive online teaching/learning<br />

Georgia Narsavage (Columbia, United States of America)<br />

Introduction to the workshop including the 'quality matters' (QM) evaluation<br />

Georgia Narsavage (Columbia, United States of America)<br />

Workshop: Design and evaluate a section of an online course<br />

Georgia Narsavage (Columbia, United States of America), Geraldine Clarebout (Maastricht, Netherlands)<br />

1720<br />

1721<br />

1722<br />

10:10 Discussion and conclusion 1723<br />

Room ICC Capital Suite<br />

14<br />

Session 369 10:45 - 12:45<br />

Registration for this session is additional to the congress registration fee and is €40 on site, €35 standard or €25 for early bird<br />

registration.<br />

Professional development workshop: PD4 How to deal with difficult people<br />

Aims : Access educational materials here<br />

To increase the ability develop effective approaches to dealing with challenging situations; to use effective communication skills to raise<br />

concerns; to identify difficult personality types and utilise specific strategies for dealing with them.<br />

Target audience : Allied health professional, Clinician, Fellow, Junior member, Patient, Public health official, Respiratory physician,<br />

Trainee, Student, Nurse, Physiotherapist, Researcher, Social worker, Respiratory therapist, Educationalist<br />

Chairs : Nicolino Ambrosino (Volterra, Italy)<br />

10:45 Introduction by the chair 2121<br />

10:50<br />

11:10<br />

11:35<br />

12:00<br />

12:25<br />

What makes a situation challenging?- Remembering that impact may be different than intent- Ho<br />

w perception impacts our view- Gaining psychological distance as you prepare an approach- Recognisin<br />

g that emotions may cloud your judgment and behaviour- Small group discussion: What types of<br />

behaviour are most challenging for you and why?<br />

Louellen N. Essex (Minnesota, United States of America)<br />

When you want to use a communication approach: A step-by-step template- Describing the problem<br />

without using judgmental terms- Owning your own point of view- Explaining the impact of the<br />

problem- Listening carefully to the response- Negotiating solutions- What to do if you cannot reach<br />

agreement- Skills practise in communicating with difficult people in small groups<br />

Louellen N. Essex (Minnesota, United States of America)<br />

Applying the communication approach to common difficult situations- Case discussion in small groups:<br />

What would you say/do?<br />

Louellen N. Essex (Minnesota, United States of America)<br />

When you want to use a coping approach:- If communication does not work, managing the situation “in<br />

the moment”- Examples of what to say and do when certain behaviours occur- Skills practise in triads<br />

Louellen N. Essex (Minnesota, United States of America)<br />

In summary: Commit-Own-Notice-Frame-Identify-Determine-Evaluate-Negotiate-<br />

Collaborate–Experiment = CONFIDENCE<br />

Louellen N. Essex (Minnesota, United States of America)<br />

2122<br />

2123<br />

2124<br />

2125<br />

2126<br />

12:35 Questions and answers 2127<br />

Room ICC Capital Suite<br />

14<br />

Session 433 13:00 - 14:30<br />

Registration for this session is additional to the congress registration fee and is €40 on site, €35 standard or €25 for early bird<br />

registration.<br />

Professional development workshop: PD5 Establishing core facilities for measuring clinical trial<br />

outcomes<br />

Experience from the European Cystic Fibrosis Society (ECFS) Clinical Trials Network (CTN)<br />

Aims : Access educational materials here<br />

To identify hurdles to the inclusion and acceptance of broader outcome measures in clinical trials; to describe the benefits of<br />

standardisation and the roles and requirements of a core facility giving the ECFS CTN as example; to understand potential interactions<br />

between the core facility, commercial sponsors, and the trial networks.<br />

119 26.08.2016

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!